| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 104, 1709-1715, Copyright © 1979 by Endocrine Society
ARTICLES |
M Brown, J Rivier and W Vale
Somatostatin (SRIF) has been tested for its actions on the central nervous system to affect glucoregulation. In doses ineffective when given systemically , SRIF and SRIF analogs given intracisternally (ic) reduce hyperglycemia and hyperglucagonemia after ic bombesin administration. The SRIF analog, des-AA1, 2, 4, 5, 12, 13-[D-Trp8]SRIF, decreases plasma insulin and elevates plasma glucose and glucagon when given systemically. However, when given ic, this peptide prevents the rise in glucose and glucagon after ic bombesin administration and is 10 times more potent than SRIF in reducing bombesin-induced hyperglycemia. Other analogs of SRIF and various unrelated peptides were found to be ineffective in reducing bombesin-induced hyperglycemia. des-AA1, 2, 4, 5, 12, 13-[D-Trp]SRIF prevented the hyperglycemia induced by surgical stress or by ic administration of beta-endorphin or carbacol. des-AA1, 2, 4, 5, 12, 13-[D-Trp]SRIF given ic did not prevent hyperglycemia induced by systemic administration of epinephrine, arginine, or glucagon. These studies suggest that SRIF and its analogs may act within the brain to affect glucoregulation.
This article has been cited by other articles:
![]() |
M Yoneda, K Nakamura, Y Nakade, M Tamano, T Kono, H Watanobe, T Shimada, H Hiraishi, and A Terano Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain Gut, February 1, 2005; 54(2): 282 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Lekas, S. J. Fisher, B. El-Bahrani, M. van Delangeryt, M. Vranic, and Z. Q. Shi Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade J Appl Physiol, August 1, 1999; 87(2): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokohama, M. Yoneda, K. Nakamura, and I. Makino Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G622 - G628. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nouel, G. Gaudriault, M. Houle, T. Reisine, J.-P. Vincent, J. Mazella, and A. Beaudet Differential Internalization of Somatostatin in COS-7 Cells Transfected with SST1 and SST2 Receptor Subtypes: A Confocal Microscopic Study Using Novel Fluorescent Somatostatin Derivatives Endocrinology, January 1, 1997; 138(1): 296 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Tache, Y Goto, M. Gunion, W Vale, J River, and M Brown Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor Science, November 25, 1983; 222(4626): 935 - 937. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |